COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER

The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticue...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIN, Chia-Yang, Li Fen LEE, Denis HEALY, Shihao CHEN, Margaret MARSHALL, Shobha POTLURI, Naoki SAWADA
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIN, Chia-Yang
Li Fen LEE
Denis HEALY
Shihao CHEN
Margaret MARSHALL
Shobha POTLURI
Naoki SAWADA
description The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticuerpo que se une específicamente a CCR4 humano y un agonista selectivo de 4-1BB, y el uso de las terapias de combinación para el tratamiento de cáncer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2016015181A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2016015181A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2016015181A3</originalsourceid><addsrcrecordid>eNrjZPBx9vd18vRzDPH091Pwd1Nw9AOiEE9dZ-cgEzDLyd8lEshwUXBUMNE1dHJScHT39_MMDlFw8w9SCAlyBer0c1dwdvRzdg3iYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoZmBoamhhaGjsZEKQIAiuMtVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER</title><source>esp@cenet</source><creator>LIN, Chia-Yang ; Li Fen LEE ; Denis HEALY ; Shihao CHEN ; Margaret MARSHALL ; Shobha POTLURI ; Naoki SAWADA</creator><creatorcontrib>LIN, Chia-Yang ; Li Fen LEE ; Denis HEALY ; Shihao CHEN ; Margaret MARSHALL ; Shobha POTLURI ; Naoki SAWADA</creatorcontrib><description>The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticuerpo que se une específicamente a CCR4 humano y un agonista selectivo de 4-1BB, y el uso de las terapias de combinación para el tratamiento de cáncer.</description><language>eng ; spa</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170525&amp;DB=EPODOC&amp;CC=MX&amp;NR=2016015181A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170525&amp;DB=EPODOC&amp;CC=MX&amp;NR=2016015181A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIN, Chia-Yang</creatorcontrib><creatorcontrib>Li Fen LEE</creatorcontrib><creatorcontrib>Denis HEALY</creatorcontrib><creatorcontrib>Shihao CHEN</creatorcontrib><creatorcontrib>Margaret MARSHALL</creatorcontrib><creatorcontrib>Shobha POTLURI</creatorcontrib><creatorcontrib>Naoki SAWADA</creatorcontrib><title>COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER</title><description>The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticuerpo que se une específicamente a CCR4 humano y un agonista selectivo de 4-1BB, y el uso de las terapias de combinación para el tratamiento de cáncer.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBx9vd18vRzDPH091Pwd1Nw9AOiEE9dZ-cgEzDLyd8lEshwUXBUMNE1dHJScHT39_MMDlFw8w9SCAlyBer0c1dwdvRzdg3iYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoZmBoamhhaGjsZEKQIAiuMtVQ</recordid><startdate>20170525</startdate><enddate>20170525</enddate><creator>LIN, Chia-Yang</creator><creator>Li Fen LEE</creator><creator>Denis HEALY</creator><creator>Shihao CHEN</creator><creator>Margaret MARSHALL</creator><creator>Shobha POTLURI</creator><creator>Naoki SAWADA</creator><scope>EVB</scope></search><sort><creationdate>20170525</creationdate><title>COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER</title><author>LIN, Chia-Yang ; Li Fen LEE ; Denis HEALY ; Shihao CHEN ; Margaret MARSHALL ; Shobha POTLURI ; Naoki SAWADA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2016015181A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIN, Chia-Yang</creatorcontrib><creatorcontrib>Li Fen LEE</creatorcontrib><creatorcontrib>Denis HEALY</creatorcontrib><creatorcontrib>Shihao CHEN</creatorcontrib><creatorcontrib>Margaret MARSHALL</creatorcontrib><creatorcontrib>Shobha POTLURI</creatorcontrib><creatorcontrib>Naoki SAWADA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIN, Chia-Yang</au><au>Li Fen LEE</au><au>Denis HEALY</au><au>Shihao CHEN</au><au>Margaret MARSHALL</au><au>Shobha POTLURI</au><au>Naoki SAWADA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER</title><date>2017-05-25</date><risdate>2017</risdate><abstract>The present disclosure describes combination therapies comprising an antibody which specifically binds to human CCR4 and a selective 4-1BB agonist, and the use of the combination therapies for the treatment of cancer. La presente descripción describe terapias de combinación que comprenden un anticuerpo que se une específicamente a CCR4 humano y un agonista selectivo de 4-1BB, y el uso de las terapias de combinación para el tratamiento de cáncer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2016015181A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINATION OF AN ANTI-CCR4 ANTIBODY AND A 4-1BB AGONIST FOR TREATING CANCER
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T11%3A20%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIN,%20Chia-Yang&rft.date=2017-05-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2016015181A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true